33% of antibiotics prescribed by NHS are given without associated diagnosis, England’s Chief Medical Officer warns

pharmafile | February 11, 2019 | News story | Sales and Marketing AMR, Antibiotics, Dame Sally Davies, England, UK, pharma 

A third of the antibiotics prescribed by the NHS are given out despite there being no medical evidence that they are necessary, England’s Chief Medical Officer Dame Sally Davies has said.

The fight against antimicrobial resistance is being hindered by Doctors who hand out antibiotics in order to ‘validate’ that a patient is unwell, Davies claimed.

In making her point, Davies noted that around 33% of all prescriptions for antibiotics are recorded with no associated diagnosis. Prior research has found that around 20% of antibiotics prescribed by GPs are handed out inappropriately.

“It is really difficult at the moment in the NHS to know what’s used where and how often,” Dame Sally told the Westminster Health Forum.

“A third of prescriptions do not have an associated diagnosis – people are not using the [Nice] guidelines. There is a difference between what’s needed physically and what’s needed socially.

“Doctors think patients are asking for antibiotics, but actually when you talk to them they are asking for validation that they’re sick and antibiotics are the best way.”

Davies also warned of the misuse of antibiotics that occurs in other countries around the world. While farmers in the UK have reduced their use of antibiotics by 40% in recent years, lawmakers in the US have recently given the green light for citrus farmers to spray streptomycin on their crops.

Pharmaceutical companies and their efforts to boost sales have contributed to the problem of AMR.

“I don’t think this should be a free pass for companies that are behaving badly in other countries,” Davies said. “If I have a say in it bonuses for sales staff are out, dirty effluent are out, and a good many other things.”

Louis Goss

Related Content

AstraZeneca and MSD’s Lynparza receives NICE positive recommendation as a cancer maintenance treatment

UK-based pharmaceutical company AstraZeneca has announced that the National Institute for Health and Care Excellence …


Long COVID: 15 studies launched with £19.6 million government funding

The UK government has announced the launch of 15 new extensive studies, backed by £19.6 …

Drugmakers fined a record £260 million after 10,000% drug price increase

The UK’s competition authority has issued its largest ever fine of more than £260 million …

Latest content